BD Executive and Leadership Team

Tom Polen, the Chairman, Chief Executive Officer & President at BD, directs the overarching corporate strategy and long-term vision for the medical technology enterprise. Overseeing global operations, the Chairman, Chief Executive Officer & President ensures alignment between product innovation and clinical needs. This leadership role involves managing complex relationships with the Board and driving expansion across international healthcare markets. By prioritizing advancements in drug delivery and patient safety, Tom Polen directly impacts the company's ability to scale diagnostic systems. Ultimately, Polen secures the competitive position of the organization within the global medical device industry through rigorous operational oversight and strategic capital allocation. The Chairman, Chief Executive Officer & President maintains a focus on sustainable growth while addressing the evolving requirements of hospitals and laboratories worldwide, ensuring that the company remains at the forefront of medical innovation and clinical excellence.

Kathryn Wetzel, the Chief of Staff, Office of the CEO & SVP at BD, directs the administrative and strategic priorities within the executive office. Overseeing the flow of information to the leadership team, the Chief of Staff, Office of the CEO & SVP ensures that corporate objectives remain the primary focus of all departments. This leadership role involves facilitating communication between the Board and senior management to drive organizational alignment. By managing high-level initiatives, Kathryn Wetzel directly impacts the efficiency of the company's decision-making processes. Ultimately, Wetzel drives the execution of the corporate mission by ensuring that resources are allocated to the most critical medical technology projects. The Chief of Staff, Office of the CEO & SVP coordinates with various business units to maintain a cohesive strategy, supporting the company's commitment to innovation in patient safety, drug delivery, and diagnostic systems across all global operations.

Vitor Roque, the Executive Vice President & Chief Financial Officer at BD, directs the financial planning, reporting, and capital management strategies for the organization. Overseeing the fiscal health of the company, the Executive Vice President & Chief Financial Officer ensures that investments in medical technology and laboratory equipment yield sustainable returns. This leadership role involves managing investor relations and overseeing the financial risks associated with global manufacturing operations. By optimizing the balance sheet, Vitor Roque directly impacts the company's capacity for future innovation and market expansion. Ultimately, Roque drives the financial discipline necessary to support the company's mission of improving healthcare outcomes. The Executive Vice President & Chief Financial Officer coordinates with the Board to ensure transparency and long-term value creation, providing the economic foundation that allows the company to deliver advanced diagnostic systems and healthcare solutions to hospitals and laboratories on a global scale.

Nikos Pavlidis, the President, Worldwide Diagnostic Solutions at BD, directs the development and commercialization of the company's diagnostic systems and laboratory equipment. Overseeing the diagnostic business unit, the President, Worldwide Diagnostic Solutions ensures that hospitals and laboratories receive the most accurate and efficient testing tools available. This leadership role involves managing the global supply chain and product lifecycle for diagnostic platforms. By focusing on clinical accuracy, Nikos Pavlidis directly impacts the company's ability to support patient safety and early disease detection. Ultimately, Pavlidis drives the growth of the diagnostic portfolio by responding to the urgent needs of healthcare providers worldwide. The President, Worldwide Diagnostic Solutions coordinates with research teams to integrate new bioscience innovations into the diagnostic suite, ensuring that the company remains a leader in providing essential healthcare solutions that improve diagnostic speed and reliability across diverse international markets.

Ivy Parks, the President (Canada) at BD, directs the regional operations and market strategy for the company's medical technology portfolio within the Canadian healthcare sector. Overseeing local distribution and customer relationships, the President (Canada) ensures that hospitals and laboratories have access to the latest diagnostic systems and medical devices. This leadership role involves navigating regional regulatory environments and tailoring healthcare solutions to meet the specific needs of the Canadian market. By fostering strong partnerships with local healthcare providers, Ivy Parks directly impacts the company's regional performance and brand presence. Ultimately, Parks drives the growth of the business by ensuring that the company's innovations in patient safety and drug delivery are effectively implemented across the country. The President (Canada) coordinates with global leadership to align regional activities with the broader corporate mission, ensuring that the company maintains a high standard of service and clinical support throughout the region.

Sandra Ostler, the Chief Information Officer at BD, architects the digital infrastructure supporting global manufacturing and diagnostic systems. Overseeing enterprise-wide data security, the Chief Information Officer ensures that laboratory equipment and healthcare solutions remain connected and efficient. This leadership role involves integrating advanced analytics into the supply chain to optimize product delivery. By modernizing internal systems, Sandra Ostler directly impacts the operational agility of the company. Ultimately, Ostler drives the digital transformation necessary to support hospitals and healthcare providers in a data-driven environment. The Chief Information Officer manages the technological backbone of the organization, facilitating seamless communication across international regions. Through the implementation of robust cybersecurity protocols and scalable cloud platforms, Ostler ensures that the company maintains high standards of data integrity while supporting the complex needs of modern medical research and patient care facilities.

Jillian Streeter, the Manager, Quality & Chief Marketing Officer, Instrument at BD, directs the quality assurance protocols and market positioning for specialized laboratory instrumentation. Overseeing regulatory compliance, the Manager, Quality & Chief Marketing Officer, Instrument ensures that all diagnostic equipment meets rigorous safety standards before reaching healthcare providers. This leadership role involves crafting go-to-market strategies that highlight the precision and reliability of the company's bioscience tools. By aligning quality control with customer expectations, Jillian Streeter directly impacts the reputation of the brand in the medical device sector. Ultimately, Streeter drives market adoption through clear communication of technical value propositions. The Manager, Quality & Chief Marketing Officer, Instrument coordinates with engineering teams to refine product features based on clinical feedback, ensuring that the company delivers superior diagnostic solutions that enhance laboratory efficiency and patient safety across diverse global healthcare environments.

John DeFord, the Executive Vice President & Chief Technology Officer at BD, directs the research and development pipeline for medical devices and diagnostic systems. Overseeing the innovation lifecycle, the Executive Vice President & Chief Technology Officer ensures that new healthcare solutions address critical gaps in patient care. This leadership role involves collaborating with scientific teams to advance bioscience capabilities and drug delivery technologies. By fostering a culture of technical excellence, John DeFord directly impacts the company's ability to bring life-saving equipment to market. Ultimately, DeFord drives the long-term technological roadmap that sustains the company's leadership in the medical technology industry. The Executive Vice President & Chief Technology Officer manages the integration of emerging technologies into existing product lines, ensuring that the company remains a pioneer in medical innovation while meeting the complex demands of hospitals and laboratories on a global scale.

Meera Gopalakrishnan, the Senior Vice President and Global Chief Marketing Officer at BD, directs the worldwide brand strategy and commercial outreach for the company's medical technology portfolio. Overseeing global marketing initiatives, the Senior Vice President and Global Chief Marketing Officer ensures that healthcare providers understand the value of the company's diagnostic systems and laboratory equipment. This leadership role involves analyzing market trends to identify growth opportunities in patient safety and drug delivery. By executing targeted campaigns, Meera Gopalakrishnan directly impacts the company's market share and customer engagement levels. Ultimately, Gopalakrishnan drives the strategic communication that positions the company as a trusted partner for hospitals and laboratories. The Senior Vice President and Global Chief Marketing Officer coordinates with regional teams to tailor messaging to specific healthcare needs, ensuring that the company maintains a strong, consistent presence across all international markets while supporting the broader mission of improving patient outcomes.

Devon Peterson, the Director and Chief of Staff To Chief Revenue Officer at BD, directs the operational workflows that support revenue generation and sales performance. Overseeing the alignment of sales strategies, the Director and Chief of Staff To Chief Revenue Officer ensures that the commercial organization functions with maximum efficiency. This leadership role involves managing cross-functional projects that bridge the gap between product development and market execution. By streamlining internal processes, Devon Peterson directly impacts the company's ability to meet financial targets and support healthcare providers. Ultimately, Peterson drives the operational excellence required to sustain revenue growth in the competitive medical technology sector. The Director and Chief of Staff To Chief Revenue Officer coordinates with executive leadership to implement strategic initiatives that enhance the company's reach, ensuring that the sales force remains equipped to deliver high-quality diagnostic systems and medical devices to hospitals and laboratories worldwide.